Answers are grounded in this paper and cite their sources.
Drug resistance remains an unmet challenge in a variety of neurological disorders, but epilepsy is probably the refractory disease that has received most experimental, preclinical, and therapeutic attention. Although resective surgery continues to improve our ability to provide seizure relief, new discoveries have potential as alternative therapeutic approaches to multiple drug resistance. As discussed here, the field is replete with controversies and false starts, in particular as it concerns the existence of genetic predisposition to inadequate pharmacological seizure control.
No takes yet. Share an insight, caveat, or question.
Marchi et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: